Peptide purity is the percentage of a compound sample that is the intended target peptide — as opposed to synthesis byproducts, degradation products, reagent residues, or other impurities that remain after manufacturing and purification. A peptide labeled as 99% pure means that 99% of the measurable material in the sample is the target compound, with the remaining 1% consisting of other detectable substances.
Purity is not a fixed property of a compound — it reflects the quality of the synthesis process, the effectiveness of the purification step, and the integrity of storage and handling from production through delivery. Two vials labeled as the same compound from different suppliers can have dramatically different purity profiles, which is why independent analytical testing rather than supplier claims is the only reliable way to verify what a vial actually contains.
The validity of research data depends directly on the purity of the compounds used to generate it. An impure peptide introduces uncontrolled biological variables into every experiment it is used in — because the impurities present alongside the target compound may themselves produce biological effects that are then mistakenly attributed to the compound being studied.
This is particularly relevant in cell culture and receptor binding research, where small amounts of biologically active impurities can shift dose-response curves, activate off-target receptors, or produce inflammatory artifacts that confound results. A research protocol using a compound of unknown purity generates data of unknown reliability — and that data cannot be used to draw valid conclusions about the target compound’s mechanism.
For research peptides specifically, purity matters at every stage. At the sourcing stage, it determines whether the compound is suitable for use in a given protocol. At the experimental stage, it determines whether observed effects can be attributed to the target compound. At the publication stage, it determines whether the data is reproducible by other researchers using different batches of the same compound.
View batch-specific purity data for all Patriot Peptides compounds on our Certificates of Analysis page.
High-Performance Liquid Chromatography — HPLC — is the standard analytical method for measuring peptide purity. It is a separation technique: it physically separates the components of a sample from each other based on their chemical properties, then measures each component individually as it exits the separation column.
For peptide analysis, reversed-phase HPLC (RP-HPLC) is the standard approach. The separation column contains a stationary phase — typically C18 or C8 octadecyl silica beads — with hydrophobic (non-polar) surface chemistry. The mobile phase is a liquid solvent mixture, typically water and acetonitrile with a small amount of trifluoroacetic acid, that flows through the column under high pressure — typically 50 to 400 bar.
When a dissolved peptide sample is injected into the HPLC system, the individual components of the sample interact differently with the hydrophobic stationary phase as the mobile phase carries them through the column. Less hydrophobic components — including many common synthesis impurities — interact weakly with the stationary phase and elute from the column early. More hydrophobic compounds interact more strongly and take longer to elute. The target peptide elutes at a characteristic retention time determined by its specific amino acid composition and hydrophobic character.
As each component exits the column, a UV detector measures its absorbance at 214 to 220 nm — the wavelength at which the peptide bond absorbs ultraviolet light. All peptides absorb at 214 nm because all peptides contain peptide bonds. This universal detection means the method captures every peptide-containing component in the sample, not just the target compound. Aromatic amino acids — tryptophan, tyrosine, phenylalanine — also absorb at 280 nm, which some methods use as a supplementary detection wavelength.
The detector output is the chromatogram — a graph of UV absorbance over time, where each peak represents a component that eluted from the column at that retention time.
A chromatogram is the visual output of an HPLC analysis — a graph with time on the horizontal axis and UV detector signal intensity on the vertical axis. Each peak in the chromatogram corresponds to a component that separated from the sample and passed through the UV detector at a specific time.
In a high-purity peptide sample, the chromatogram shows one dominant peak — the target compound — with small minor peaks representing residual impurities. The area under each peak is proportional to the amount of that component in the sample. The target peptide peak area divided by the sum of all peak areas gives the purity percentage.
Using the real BPC-157 COA data from Patriot Peptides batch 00177 as a working example:
Peak Time (min) Area % Assignment
1 5.21 99.10 BPC-157
2 5.43 0.52 Unassigned
3 5.66 0.38 UnassignedThe main peak at 5.21 minutes accounts for 99.10% of the total detected area — this is the BPC-157 purity result. The two minor peaks at 5.43 and 5.66 minutes account for 0.52% and 0.38% respectively. These are synthesis-related impurities — small amounts of byproduct compounds that remained after purification. At these percentages, they are within normal and acceptable limits for research-grade material.
The shape of the main peak matters as well as its area. A sharp, symmetrical peak indicates a single well-resolved compound. A broad or asymmetric peak, or two partially merged peaks, may indicate co-elution — two compounds eluting at nearly the same retention time that the method did not fully resolve into separate peaks. Co-elution is one of the limitations of single-method HPLC, which is why mass spectrometry identity confirmation is used alongside HPLC purity analysis rather than as a replacement for it.
The purity percentage is calculated from the chromatogram peak areas using a straightforward formula:
Purity % = (Area of target compound peak /
Sum of all peak areas) × 100For the BPC-157 example above, if the three peaks have areas of 99.10, 0.52, and 0.38 as percentages of total area, the purity calculation is already expressed as area percentages — the 99.10% figure is the target compound peak as a percentage of the total detected area. No conversion is needed when the COA reports area percentages directly.
This area percentage method assumes that all detected components have equivalent UV absorption per unit quantity at the detection wavelength — a reasonable approximation for peptide impurities that are structural variants of the target peptide, since they will contain similar peptide bonds. For impurities with very different structures or amino acid compositions, the absorption coefficient differences can cause the area percentage to over- or underestimate the mass percentage of those impurities. For typical synthesis-related impurities in a high-purity peptide sample, this effect is small and does not materially affect the purity result.
The difference between 98% and 99% purity sounds small — one percentage point — but its practical meaning depends on what the remaining 1% to 2% consists of and what research application the compound is being used for.
At 98% purity, 2% of the sample is something other than the target compound. For a 5mg vial, that is 0.1mg of impurities. If those impurities are inert synthesis byproducts with no biological activity, the practical difference between 98% and 99% purity may be negligible for most research applications. If those impurities include biologically active structural variants of the target peptide — partially deprotected intermediates, oxidation products, or truncated sequences — the practical impact on experimental data can be more significant.
For most receptor binding studies and cell culture research, 98% purity is a functional minimum threshold. For sensitive quantitative assays where precise dose-response characterization is required, 99% or above reduces the contribution of impurities to observed effects and improves the interpretability of the dose-response data.
Patriot Peptides compounds are tested to a minimum of 99% HPLC purity before release. Browse independently tested research peptides in our Research Compounds catalog.
HPLC answers one question: how pure is the sample? It does not answer a second equally important question: is the main compound peak actually the intended target peptide?
A compound could test at 99% purity by HPLC while being the wrong peptide entirely — if the wrong compound was synthesized or labeled, it would show a single dominant peak at high purity that HPLC alone cannot identify. Mass spectrometry answers the identity question by measuring the molecular weight of the compound.
Mass spectrometry ionizes the sample molecules — giving them an electrical charge — and then separates them by their mass-to-charge ratio. The resulting mass spectrum shows the molecular weight of the detected compounds. For a synthetic peptide, the theoretical monoisotopic mass is calculated from the amino acid sequence and molecular formula using known atomic masses. When the measured monoisotopic mass matches the theoretical reference mass within accepted analytical tolerance — typically 0.02 Da for high-resolution instruments — identity is confirmed.
For BPC-157 from Patriot Peptides batch 00177:
Expected Monoisotopic Mass: 1418.70 Da
Measured Monoisotopic Mass: 1418.71 Da
Difference: 0.01 Da — within tolerance
Identity result: ConformsThe 0.01 Da difference between expected and measured mass is well within the 0.02 Da tolerance for high-resolution mass spectrometry — confirming that the dominant HPLC peak is BPC-157 and not a structurally similar compound of similar hydrophobicity that might co-elute under the same chromatographic conditions.
HPLC and mass spectrometry are complementary tests that answer different questions. A COA with both provides complete quality verification. A COA with HPLC only tells you the sample is pure but not what it is. A COA with mass spectrometry only tells you the compound’s molecular weight but not the percentage of that compound in the sample.
HPLC purity testing is the industry standard for research peptides, but understanding its limitations is important for interpreting COA data accurately.
Co-eluting impurities are the most significant technical limitation. If an impurity has a retention time close enough to the target compound that HPLC does not fully resolve the two peaks, the impurity’s area contribution is counted within the main peak area — artificially inflating the reported purity. Sophisticated laboratories address this by using multiple chromatographic conditions or complementary separation methods to confirm that apparent single-peak purity reflects a genuinely pure sample rather than unresolved co-elution.
Absorption coefficient differences mean that impurities with significantly different amino acid compositions may contribute more or less UV absorbance per unit mass than the target peptide at 214 nm. For most synthesis-related impurities that are structural variants of the target — truncated sequences, deletion analogs, side-chain modified variants — the absorption differences are small. For chemically unrelated impurities, the correction can be more significant.
Snapshot in time — purity testing reflects the compound’s state at the time of testing. Improper storage or handling after testing can degrade the compound, reducing the actual purity below the COA-stated value even when the COA is accurate. A peptide that tested at 99% but was stored at room temperature for six months is not still 99% pure. For guidance on maintaining compound integrity after receipt, see our Research Peptide Storage and Handling guide.
Endotoxin and sterility are not purity — a 99% pure peptide can still be heavily contaminated with bacterial endotoxins or microbial organisms that HPLC would not detect. Endotoxin screening and sterility testing are separate tests that address contamination categories entirely outside the scope of purity analysis.
Every Patriot Peptides batch goes through a four-point independent quality verification process before it ships. HPLC purity analysis confirms the compound percentage meets or exceeds 99%. Mass spectrometry identity confirmation verifies the measured monoisotopic mass matches the expected reference mass for the target compound. Endotoxin screening tests for bacterial lipopolysaccharides that could confound sensitive research applications. Sterility testing confirms the absence of viable microbial contamination.
All testing is performed by independent certified third-party laboratories — The BioCraft Lab and Stratton Lab Inc — with no commercial relationship to Patriot Peptides beyond the testing contract. Batch-specific COAs covering all four test results are available for every product and tied to specific lot numbers so you can match your vial’s documentation precisely.
View complete COA documentation at our Certificates of Analysis page or read our guides on What Is a COA and How to Read a Peptide COA for more detail on interpreting the test results.
How is peptide purity tested?
Peptide purity is primarily tested using reversed-phase HPLC, which separates the components of a sample through a hydrophobic stationary phase column and measures each component’s UV absorbance as it exits the column. The result is a chromatogram with peaks representing each detected component. Purity is calculated as the target compound peak area divided by the sum of all peak areas. Mass spectrometry is used alongside HPLC to confirm the molecular identity of the main compound peak.
What does HPLC stand for and how does it work for peptides?
HPLC stands for High-Performance Liquid Chromatography. For peptides, reversed-phase HPLC uses a C18 or C8 stationary phase column and an aqueous-organic mobile phase gradient. The peptide sample is injected and flows through the column under high pressure. Components separate based on their hydrophobicity and elute at characteristic retention times. A UV detector at 214 to 220 nm measures each component as it exits the column, producing a chromatogram.
What is a chromatogram in peptide testing?
A chromatogram is the graphical output of an HPLC analysis — a plot of UV detector signal versus time. Each peak represents a component that separated from the sample and passed through the detector. The area under the main peak, divided by the sum of all peak areas, gives the purity percentage of the target compound.
What is the difference between 98% and 99% purity?
At 98% purity, 2% of the sample is something other than the target compound — 0.1mg of impurities in a 5mg vial. At 99% purity, 1% is impurities — 0.05mg. The practical significance of this difference depends on whether the impurities are biologically active and what research application the compound is being used for. For sensitive quantitative assays and receptor binding studies, 99% or above improves dose-response interpretability.
Why is mass spectrometry used alongside HPLC?
HPLC confirms purity — what percentage of the sample is the dominant compound — but cannot confirm the identity of that compound. Mass spectrometry measures the molecular weight of the compound and compares it to the expected theoretical mass of the target peptide. Together, the two tests confirm both that the sample is highly pure and that the pure compound is the intended target.
Can a peptide test at high purity but still be contaminated?
Yes. HPLC purity measures chemical compound purity — the percentage of the sample that is the target peptide versus other chemical compounds. It does not detect bacterial endotoxins or microbial contamination. A 99% pure peptide can still contain biologically significant levels of endotoxin or microbial contamination that HPLC would not detect. Separate endotoxin screening and sterility testing are required to verify these parameters.
Where can I see Patriot Peptides’ purity test results?
Batch-specific COAs showing HPLC purity results, chromatogram peak data, mass spectrometry identity confirmation, endotoxin results, and sterility results for all Patriot Peptides compounds are available on our Certificates of Analysis page. For laboratory research use only.
All Patriot Peptides products are strictly for laboratory research use only. Not for human consumption, veterinary use, or clinical application.
Related reading: What Is a Certificate of Analysis? | How to Read a Peptide COA | Third-Party Peptide Testing Explained | Research Peptide Storage and Handling | Certificates of Analysis